There are several buprenorphine providers at EMMc\u27s Center for Family Medicine serving the greater Bangor, ME region - an area of substantial opiate use. Among the patient population of outpatient buprenorphine users, both locally and nationally, there are high rates of relapse (~32%). In order to decrease relapse rates, it\u27s first imperative to conduct a baseline review of the current buprenorphine population to identify specific types of patients who are at higher risk of relapse. By understanding the barriers to recovery, the office hopes to apply an intervention to the current program, targeting this local demographic more effectively.https://scholarworks.uvm.edu/fmclerk/1098/thumbnail.jp
The opioid crisis has warranted nationwide attention towards not only the current prescribing patter...
Objective: Expanding access to medications for opioid use disorder (OUD) is a critical strategy to c...
The problem Approximately 2.6 million Americans have opioid use disorder (OUD), but only 10.6% have ...
Opiate addiction is a major public health problem in Maine. Addiction is a chronic disease with hig...
Opioid abuse is a serious problem in Maine with a societal cost of 1.4 billion dollars. Buprenorphin...
Opioid abuse is a serious problem in Maine with a societal cost of 1.4 billion dollars. Buprenorphin...
Since the initiation of the Hub and Spoke Model in 2014, VT has been able to eliminate the waitlis...
Mindfulness has been shown to aid in addiction recovery and can help prevent relapse. The Family Med...
Background: Buprenorphine, an underutilized pharmacotherapy, can play a key role in closing the subs...
At least 2.3 million people in the U.S. have an opioid use disorder, less than 40% of whom receive e...
Vermont has expanded access to medication assisted treatment (MAT) since the onset of the opiate epi...
Opiate dependence is a prevalent problem and there is a need for current regional information for th...
Introduction: Opioid addiction and abuse continues to reach epidemic status in the United States. Ma...
Implementing effective opiate detoxification is critical to the health and well-being of the Lewisto...
2.6 million Americans have opioid use disorder (OUD), but only 10.6% have received treatment, mainly...
The opioid crisis has warranted nationwide attention towards not only the current prescribing patter...
Objective: Expanding access to medications for opioid use disorder (OUD) is a critical strategy to c...
The problem Approximately 2.6 million Americans have opioid use disorder (OUD), but only 10.6% have ...
Opiate addiction is a major public health problem in Maine. Addiction is a chronic disease with hig...
Opioid abuse is a serious problem in Maine with a societal cost of 1.4 billion dollars. Buprenorphin...
Opioid abuse is a serious problem in Maine with a societal cost of 1.4 billion dollars. Buprenorphin...
Since the initiation of the Hub and Spoke Model in 2014, VT has been able to eliminate the waitlis...
Mindfulness has been shown to aid in addiction recovery and can help prevent relapse. The Family Med...
Background: Buprenorphine, an underutilized pharmacotherapy, can play a key role in closing the subs...
At least 2.3 million people in the U.S. have an opioid use disorder, less than 40% of whom receive e...
Vermont has expanded access to medication assisted treatment (MAT) since the onset of the opiate epi...
Opiate dependence is a prevalent problem and there is a need for current regional information for th...
Introduction: Opioid addiction and abuse continues to reach epidemic status in the United States. Ma...
Implementing effective opiate detoxification is critical to the health and well-being of the Lewisto...
2.6 million Americans have opioid use disorder (OUD), but only 10.6% have received treatment, mainly...
The opioid crisis has warranted nationwide attention towards not only the current prescribing patter...
Objective: Expanding access to medications for opioid use disorder (OUD) is a critical strategy to c...
The problem Approximately 2.6 million Americans have opioid use disorder (OUD), but only 10.6% have ...